Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Healthcare Medical Devices
Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Therma Bright Inc > This just ou
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(758)
•••
Comment by Smokey1958on Jan 07, 2022 12:31pm
163 Views
Post# 34293413

RE:RE:RE:RE:RE:RE:RE:RE:This just ou

RE:RE:RE:RE:RE:RE:RE:RE:This just ou

They can't sell them regardless of outcome ....that's the whole point of authorization. Several companies in the US have tried to do this ....and there are serious consequences. As such it could be an incredible financial risk for THRM to spend money on getting tests ready prior to an FDA EUA.

The testing going on now for Omicron will be with us for months ....and quite frankly the next variant is just around the corner. AcuVid still has a significant role to play.

GLTY ...and GLTE holding patiently!!!

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-december-28-2021


NTRSandman wrote: You're missing the point.  They could start producing now to get a jump on production.  The demand is high and it is still a very viable test. They could sell them regardless of outcome and recoup their costs. 

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities